MKM Partners Reiterated Buy on Five Below (FIVE) Following Strong 4Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Pre-Open Stock Movers 03/23: (SQNM) (IONS) (AFFX) Higher; (SAGE) (SUNE) (KKD) Lower (more...)
March 23, 2016 9:35 AM EDTSage Therapeutics, Inc. (NASDAQ: SAGE) 13.3% LOWER; Kerrisdale Capital Short
SunEdison, Inc. (NASDAQ: SUNE) 12.8% LOWER; Stifel suspends rating, Axiom Capital cuts target to $0.22 following DIP discussions
Pieris Pharma (NASDAQ: PIRS) 11.7% HIGHER; reported Q4 EPS of ($0.07), versus ($0.21) reported last year. Revenue for the quarter came in at $2.14 million, versus $3.27 million reported last year.
Celator Pharmaceuticals, Inc.... More
After-Hours Stock Movers 03/22: (SCS) (AFFX) (DF) Higher; (KKD) (NKE) (RHT) Lower (more...)
March 22, 2016 6:10 PM EDTPieris Pharma (NASDAQ: PIRS) 11.7% HIGHER; reported Q4 EPS of ($0.07), versus ($0.21) reported last year. Revenue for the quarter came in at $2.14 million, versus $3.27 million reported last year.
Krispy Kreme Doughnuts (NYSE: KKD) 6.4% LOWER; reported Q4 EPS of $0.22, $0.01 better than the analyst estimate of $0.21. Revenue for the quarter came in at $130.4 million versus the consensus estimate of $133.02 million. Systemwide domestic same store sales rose 1.6%, including a 0.2% gain at Company shops; constant currency international franchise same store sales declined 7.1%. GUIDANCE: Krispy... More
Five Below (FIVE) Tops Q4 EPS by 1c
March 22, 2016 4:03 PM EDTFive Below (NASDAQ: FIVE) reported Q4 EPS of $0.77, $0.01 better than the analyst estimate of $0.76. Revenue for the quarter came in at $326.4 million versus the consensus estimate of $323.74 million.
Comparable store sales increased 3.6%.
GUIDANCE:
Five Below sees Q1 2016 EPS of... More
